The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumMost Popular - Exact Sciences (EXAS) on Thursday released the long-awaited results of its DeeP-C trial examining the use of its Cologuard test in the detection of CRC … Continue Reading
Read nowMost Popular - Intercept Pharmaceuticals’ (ICPT) shares immediately took off from their late October IPO price of $15 per share, soaring to a closing high of $41.70 on … Continue Reading
Read nowInterviews - On April 11, PropThink hosted an Interview and Q&A (via conference call) for PropThink subscribers with Dr. Scott Chambers, a leading patent attorney and former … Continue Reading
Read nowLong Ideas - On Tuesday, the FDA ruled that generic drug-makers are barred from selling copies of older, easily abused formulations of Purdue Pharma’s well-known pain killer OxyContin, … Continue Reading
Read nowLong Ideas - Since our last report on Achillion Pharmaceuticals (ACHN) in November, shares have turned up a muted performance, losing around 7%. Through February, shares rose steadily, … Continue Reading
Read nowLong Ideas - Shares of Sarepta Therapeutics (SRPT) turned volatile Monday after the close ($32-$49) as the company announced the results of its recent end-of-Phase-II meeting with the FDA, a … Continue Reading
Read nowLong Ideas - The news this week that Thermo Fisher Scientific (TMO) will be coughing up $13.6B to acquire Life Technologies’ (LIFE) finally brought to earth rumors that … Continue Reading
Read now
